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ABSTRACT
Genome-wide association studies have become
a popular strategy to find associations of genes
to traits of interest. Despite the high-resolution
available today to carry out genotyping studies,
the success of its application in real studies has
been limited by the testing strategy used. As an
alternative to brute force solutions involving the
use of very large cohorts, we propose the use of
the Gene Set Analysis (GSA), a different analysis
strategy based on testing the association of
modules of functionally related genes. We show
here how the Gene Set-based Analysis of Poly-
morphisms (GeSBAP), which is a simple imple-
mentation of the GSA strategy for the analysis of
genome-wide association studies, provides a signif-
icant increase in the power testing for this type of
studies. GeSBAP is freely available at http://bioinfo
.cipf.es/gesbap/
INTRODUCTION
Genome-wide association studies (GWAS) use high-
resolution maps of markers (Single Nucleotide Poly-
morphisms - SNPs - and, in some platforms, Copy
Number Variations - CNVs - too) along the genome to
look for allele frequency diﬀerences between cases (e.g.
individuals with a certain disease or trait) and controls.
A signiﬁcant frequency diﬀerence is taken as an indication
of the presence of functional variants in the DNA
sequence related to the disease or trait in question
within the genomic region corresponding to the markers
(1). Despite the high resolution available to interrogate the
genomes (e.g. more than 1.8 million markers, half of them
SNPs, in the Aﬀymetrix 6.0 chip), the current testing
strategies that considers markers independently results in
weak, usually non-signiﬁcant, associations (2). Thus under
this conventional testing paradigm, only consortia analys-
ing very large cohorts were successful in ﬁnding clear and
reproducible results (3).
However, a new paradigm inspired in systems biology
has recently been adopted in other areas, such as tran-
scriptomics (4). Since the concept aimed at is the func-
tional association, it might occur that individual genes
are not the best proxies for such concept. Actually, it
is widely accepted that conventional biological functions,
in the way we understand them, can rarely be attributed
only to an individual molecule. Instead, most of the
biological functionality of the cell arises from complex
interactions between their molecular components that
deﬁne operational interacting entities or modules of func-
tionally related genes (5). In the case of genetic traits, it is
generally believed that multigenicity reﬂects disruptions
in proteins that participate in a protein complex or a in
a pathway (6). Accordingly, Gene Set Analysis (GSA)
methods aim to test the activity of such modules instead
of testing the activity of individual genes (7,8). The extrap-
olation of this concept to other ﬁelds, and in particular to
the study of complex traits by GWAS, where combina-
tions of mutations in diﬀerent genes can globally aﬀect a
pathway making it diﬃcult to ﬁnd detectable associations
in individual genes but not in the pathway, has recently
been suggested (9–11). Actually, the application of this
emergent concept (also known as pathway-based analysis)
to the analysis of GWAS is already producing new and
original results for diﬀerent pathologies (12–14). Although
stand-alone software is available for this type of analysis
(9,11,15), no web servers with better user-interface are
available for experimentalists to use.
The Gene Set-based Analysis of Polymorphisms
(GeSBAP) web server can input lists of SNP or CNV
identiﬁers arranged according to a parameter accounting
for the association (P-value) and returns a collection of
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studied. Lists of genes belonging to such processes can
easily be obtained for further validation.
RATIONALE FOR EXPANDING GENE-SET
ANALYSIS CONCEPTS TO THE STUDY
OF POLYMORPHISMS
The rationale behind the GeSBAP approach relies on the
use of a testing strategy that target damaged functional-
ities which can produce the ﬁnal phenotype. Most of the
traits analysed in GWAS experiments are multigenic.
Even in the cases that such traits depend on a unique
main gene, there are other modiﬁer genes that modulate
the phenotype. The main problem with GWAS is that
testing markers independently results in weak, usually
non-signiﬁcant, associations of them to the trait (2).
Since multigenicity is generally caused by diﬀerent combi-
nations of mutations whose only common feature is their
belonging to a pathway (or, generally speaking, to a func-
tional unit), the GeSBAP approach proposed here, where
the entity tested is the pathway, seems the natural way
of discovering associations in GWAS.
DESCRIPTION OF THE PROGRAM
GeSBAP is a web-server written in Java with a core that
essentially conducts the test written C++. The program
is running in a high-end cluster with 10 dedicated Intel
XEON Quad-Core CPUs at 2.0GHz (summing up
a total of 40 cores) with a large amount of RAM (total
60 GB).
The default mode of use is the traditional ‘anonymous
user’. In this case, the results are maintained only for 1day
and then deleted. The program also allows registered
users. An account can be created, which can be later
used after the corresponding login. The results of the ses-
sions are preserved in the account and can be recovered in
future sessions after login.
Input
The program inputs a tab-delimited list of polymorphisms
(SNP and/or CNV) along with the corresponding P-value
of the association. It is also possible to enter more pro-
cessed data, such a list of genes with the corresponding
P-value of association. Any of the most common gene
identiﬁers can be used given that GeSBAP uses internally
the INFRARED engine for gene ID conversion used in
the Babelomics package (16). Finally, data can also be
input in the format of the popular PLINK program
(17), which performs the association test and obtains the
corresponding list of P-values.
At present only human, mouse and rat SNPs can be
used in the program. The user can choose to test one or
several functional categories among Gene Ontology (GO)
(18), KEGG (19) and Biocarta (http://cgap.nci.nih.gov/
Pathways/BioCarta_Pathways) pathways. Several ﬁlters
can be applied to use subsets of any of these categories,
which essentially involve ﬁltering for maximum and min-
imum number of genes in the terms tested, ﬁltering by
keywords and, in the case of GO, ﬁltering by levels in
the GO hierarchy.
Testing strategy
Given a list of genes ranked by any criteria, GSA is used
to ﬁnd enrichments of gene sets signiﬁcantly associated
to high (or low) values of the rank. Here, the ranking
criterion for the genes is derived from the associations of
the SNPs to the trait studied. In particular, the program
uses the –log(P-value) of the association test correspond-
ing to the case–control comparison. The program selects
the polymorphisms (SNPs or CNVs) that map into genes
or in their neighbourhoods (5kb). Among all the poly-
morphisms corresponding to each gene, the one with the
highest association to the trait studied is taken as a proxy
of the gene. Then, all the genes represented in the GWAS
(usually the complete genome) are mapped to the corre-
sponding functional categories previously selected by the
user and ranked accordingly to their proxy polymorph-
isms. Finally, a GSA test (10) is used to check for func-
tional categories showing signiﬁcant association to the
trait studied. The signiﬁcant functional terms along with
the corresponding P-values [adjusted for multiple testing
(20)] are listed in the output.
Output and an example
The output of the programs provides a general overview
on the functional categories found as signiﬁcantly asso-
ciated to the trait studied. Figure 1 shows the representa-
tion of such summary. A table including the signiﬁcant
functional categories along with their corresponding
P-values and the genes included in each one is provided.
In addition, when GO terms are being analysed, a graphi-
cal representation of the signiﬁcant terms within the GO
hierarchy is also provided. The GO viewer implemented in
the Babelomics package (16) is used for this purpose.
As an example of the application of the program, we
show the analysis of a breast cancer case–control from the
CGEMs initiative (22), in which a total of 528 173 SNPs
were genotyped in 1145 post-menopausal women with
invasive breast cancer and 1142 controls. The original
study identiﬁed four SNPs in intron 2 of FGFR2 (which
encodes a receptor tyrosine kinase) that were highly asso-
ciated with breast cancer (22). The GeSBAP analysis of
the resulting list of 18000 genes ranked by –log(P-value)
revealed a considerable number of biological processes
associated with risk of sporadic postmenopausal breast
cancer (23) where the conventional tests only detected a
unique gene (22). Figure 1 represents the GO biological
processes detected as signiﬁcantly associated to the cancer,
among them ‘transmembrane receptor protein tyrosine
kinase signaling pathway’ (GO:0007169, False Discovery
Rate (FDR)-adjusted P-value=1.7310
03) and ‘regu-
lation of signal transduction’ (GO:0009966, FDR-
adjusted P-value=4.4510
03) in which FGFR2 is
included. Figure 2 represents a summary of these GO
terms mapped within the GO hierarchy. Supplementary
Figure 1 displays the complete relationships among all
the GO terms found. Notably, some of these processes
have been log-standing linked to human neoplasia
Nucleic AcidsResearch, 2009, Vol.37, WebServer issue W341although not at the germline genetic level, in any case as
comprehensively as proposed here. The role of RAS signal
transduction in tumorigenesis is well-established (24),
but this study will expand its involvement into cancer sus-
ceptibility by suggesting that several genes annotated
with the corresponding GO term play a key role in
risk of breast cancer. This term is a children of Cell
Communication and a parent of Rho signaling, which
then provides a global view of the cellular alteration in
breast cancer susceptibility and a more detailed link to
which components of the RAS signaling may be altered,
respectively. Notably, previous work have linked the Rho
guanine nucleotide exchange factor AKAP13 (signiﬁcant
here as part of the ‘transmembrane receptor protein
tyrosine kinase signaling pathway’, GO:0007169, FDR-
adjusted P-value=1.7310
03) with familial breast
cancer (25) and two of the most recent world-wide
replicated ﬁndings include FGFR2 (signiﬁcant here as pre-
viously mentioned as part of the GO terms: ‘trans-
membrane receptor protein tyrosine kinase signaling
pathway’, GO:0007169, FDR-adjusted P-value=
1.7310
03; and ‘regulation of signal transduction’,
GO:0009966, FDR-adjusted P-value=4.4510
03)
and MAP3K1 (signiﬁcant here as part of the GO terms:
‘transmembrane receptor protein tyrosine kinase signal-
ing pathway’, GO:0007169, FDR-adjusted P-value=
1.7310
03; and ‘Rho protein signal transduction’,
GO:0007266, FDR-adjusted P-value=2.2610
02).
DISCUSSION
We have shown how the concept of GSA can easily be
extrapolated to the ﬁeld of polymorphism analysis.
An example shows how the application of this test to a
breast cancer case–control reveals a considerable num-
ber of biological processes associated with risk of spo-
radic postmenopausal breast cancer (23), where the
conventional tests only detected a unique gene
association (22).
At present, the main limitations for targeting function-
ality is our limited catalogue of functions, represented
mainly by functional annotations contained in repositories
such as GO (18), KEGG (19), Biocarta pathways, etc.
This fact not only limits the number of testable eﬀects to
the content of these repositories, but also conceptually
restricts to genes associations that can be found using
the available information. It is expectable that projects
like ENCODE (26) or the 1000 genomes (http://
www.1000genomes.org/) will help to deﬁne extra-genic
regions with functional signiﬁcance. Nevertheless, this is
not a limitation of the proposed methodology, but of the
information available. In any case, the philosophy of test-
ing groups of markers corresponding to functional units
instead of markers alone has proven to be superior to
the conventional testing schema and will increase its
scope as new functional deﬁnitions become available in
the future.
Figure 1. Plot representing a summary of the GO terms signiﬁcantly associated to the breast cancer in the case–control analysed (see text).
The length of the red bar represents the relative proportion of genes of the GO term in the partition at which the enrichment was signiﬁcant (16,21).
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Nucleic AcidsResearch, 2009, Vol.37, WebServer issue W343Despite there are other general purpose programs and
web servers for carrying out diﬀerent ﬂavours of GSA,
revised in (7,8,27) (see also http://bioinfo.cipf.es/docus/
tools-citations/functional_proﬁling/), there is no similar
application available to GeSBAP, orientated to the ana-
lysis of GWAS, that calculates association P-values
and maps SNPs or CNVs to genes previously to carry
out the GSA.
The program for the GeSBAP has been running for >6
months. The ﬁrst paper using this approach has recently
been published (23). To our knowledge, there are no other
web applications oﬀering this type of analysis.
GeSBAP is freely available at http://bioinfo.cipf.es/
gesbap/www/index.jsp.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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